Amgen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Amgen 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. 

CEO
Robert A. Bradway
CEORobert A. Bradway
Employees
31,500
Employees31,500
Headquarters
Thousand Oaks, California
HeadquartersThousand Oaks, California
Founded
1980
Founded1980
Employees
31,500
Employees31,500

AMGN Key Statistics

Market cap
182.17B
Market cap182.17B
Price-Earnings ratio
23.06
Price-Earnings ratio23.06
Dividend yield
2.91%
Dividend yield2.91%
Average volume
2.63M
Average volume2.63M
High today
$337.63
High today$337.63
Low today
$328.93
Low today$328.93
Open price
$330.00
Open price$330.00
Volume
1.93M
Volume1.93M
52 Week high
$391.29
52 Week high$391.29
52 Week low
$267.83
52 Week low$267.83

Stock Snapshot

The current Amgen(AMGN) stock price is $336.00, with a market capitalization of 182.17B. The stock trades at a price-to-earnings (P/E) ratio of 23.06 and offers a dividend yield of 2.9%.

On 2026-05-21, Amgen(AMGN) stock traded between a low of $328.93 and a high of $337.63. Shares are currently priced at $336.00, which is +2.1% above the low and -0.5% below the high.

The Amgen(AMGN)'s current trading volume is 1.93M, compared to an average daily volume of 2.63M.

During the past year, Amgen(AMGN) stock moved between $267.83 at its lowest and $391.29 at its peak.

During the past year, Amgen(AMGN) stock moved between $267.83 at its lowest and $391.29 at its peak.

AMGN News

Simply Wall St 9h
Amgen CFO Change Puts Focus On Debt, Growth And Capital Discipline

Amgen announced that long-serving CFO Peter Griffith will retire from his role. Thomas Dittrich has been appointed as incoming CFO, with the transition marking...

Amgen CFO Change Puts Focus On Debt, Growth And Capital Discipline
The Wall Street Journal 17h
Amgen Drug Gets New Warnings in Japan After Patient Deaths

Amgen said U.S. guidance for Tavneos, also known as avacopan, has included information on the risk of serious liver injury since 2021. Smith Collection / Gado /...

Amgen Drug Gets New Warnings in Japan After Patient Deaths
TipRanks 1d
Amgen Shareholders Reaffirm Board, Pay and Auditors

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

Analyst ratings

49%

of 35 ratings
Buy
40%
Hold
48.6%
Sell
11.4%

More AMGN News

TipRanks 1d
Amgen Advances Xaluritamig Trial in Hard-to-Treat Prostate Cancer

Amgen Inc (AMGN) announced an update on their ongoing clinical study. Start a conversation with TipRanks’ trusted, data-backed investment intelligence Ask Sam...

TipRanks 2d
Amgen Earnings Call Highlights Growth Amid Headwinds

Amgen Inc ((AMGN)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level data and powerful...

TipRanks 2d
Amgen Announces CFO Transition and Leadership Succession Plan

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

TipRanks 2d
Amgen CFO Peter Griffith to retire, Thomas Dittrich to succeed

Amgen (AMGN) announced the retirement of Peter Griffith, who has served as the company’s executive vice president and CFO since 2020. The company also announced...

Simply Wall St 2d
Is It Time To Reassess Amgen After Its Strong Multi Year Share Price Run

If you are wondering whether Amgen at around US$324.39 is still offering value after a solid run, this article walks through what the current price really impli...

Is It Time To Reassess Amgen After Its Strong Multi Year Share Price Run
Nasdaq 2d
See How Amgen Ranks Among Analysts' Top Dow 30 Picks

A study of analyst recommendations at the major brokerages shows that Amgen Inc (Symbol: AMGN) is the #17 broker pick, on average, out of the 30 stocks making u...

See How Amgen Ranks Among Analysts' Top Dow 30 Picks
Nasdaq 2d
Dow Analyst Moves: AMGN

The latest tally of analyst opinions from the major brokerage houses shows that among the 30 stocks making up the Dow Jones Industrial Average, Amgen is the #20...

Dow Analyst Moves: AMGN

People also own

Based on the portfolios of people who own AMGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.